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Abstracts: Researches have shown that cancer stem cells, regulated by the niche where they reside, are the roots of 
oncogenesis, relapse and metastasis. To date, very few treatments have targeted on cancer stem cells. The authors 
study that the regulated factors in the niche share the characteristics of yin-yang in the theory of traditional Chinese 
medicine, which has confirmed its therapeutic effects in the prevention and treatment of cancer. So the authors 
presume that the mechanisms of traditional Chinese medicine on the prevention and treatment of cancer may be 
related to the yin-yang balance of the niche of cancer stem cells.  
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Traditional Chinese medicine (TCM) holds the theory 
that diseases are induced by the imbalance of yin and 
yang. Cancers are no exception. Yin-yang balance 
therapy is the main principle of TCM in the prevention 
and treatment of cancer. Based on this principle, TCM 
has confirmed its therapeutic effects in the prevention 
and treatment of cancer, but the mechanisms are still 
obscure.  
Researches have shown that cancer stem cells (CSC), 
regulated by the niche where they reside, may be the 
roots of oncogenesis. To date, very few treatments have 
targeted on cancer stem cells. Moreover, we study that 
the factors in the niche, controlling CSC, resemble the 
characteristics of yin-yang. Therefore, the authors
presume that the anti-cancer mechanisms of TCM may 
be related to the yin-yang balance therapy of CSC, which 
would make it possible to interpret the effects of TCM. 
Yin-yang Balance Therapy is throughout the Whole 
Cause of Cancer Treatment 
The theory of TCM holds that the pathogenesis of all 
diseases is caused by the imbalance of yin and yang of 
the body. It is recorded in Su Wen (㋴䯂 Plain Questions) 
that “If yin and yang are in a relative equilibrium, life 
activities will be normally maintained; if yin and yang 
are separated, exhaustion of vital essence will happen.” 
The balance of yin and yang correlates with the harmony 
of the joint functions of each system, the Zang organs in 
particular. If the human body is balanced, people remain 
healthy. Otherwise, diseases or even death will occur.
Just as the origins of all the diseases, the cause of cancer 
is also induced by the imbalance of yin and yang, which 
is manifested as the stagnation of qi, coagulation of 
phlegm, stagnation of blood, and accumulation of toxic 
heat. If the imbalance of yin and yang continues, “yin
may separate from yang”, and “vital essence” be 
exhausted, leading to an ultimate stage of cancer. The 
imbalance of yin-yang is throughout the whole cause of 
cancer. So treatment principle is to restore the balance of 
yin-yang. As was proposed by two famous Chinese 
oncologists YU Ren-cun (䚕ҕᄬ) and LIU Jia-xiang (߬
௝␬), the cancer treatment should follow the principle 
of regulating yin and yang to stabilize the internal 
environment and reestablish the internal balance. Then 
tumor can be controlled, and the antipathogenic qi be 
protected, symptoms relievedˈquality of life improved, 
and the survival time prolonged.1,2  
TCM with the principle of balancing yin-yang exerted 
antitumor effects through multiple actions aiming at 
multiple targets. Experimental studies have shown that 
TCM have many effects, including inducing tumor cell 
apoptosis and differentiation, regulating cellular tra- 
nsduction pathway, suppressing tumor angiogenesis, 
inhibiting telomerase activities, regulating immune 
function, and reversing multiple drug resistance, etc.3 But 
all of these molecular mechanisms can not interpret the 
essence of TCM therapy overall.   
Cancer Stem Cells are the Roots of Oncogenesis, 
Relapse and Metastasis1
Accumulating evidence has been reported that cancers 
are organized in a hierarchy of heterogeneous cell 
populations with different biological properties and that 
the capability to sustain tumor formation and growth 
exclusively resides in a small proportion of tumor cells, 
termed CSC or tumor initiating cells. CSC have been 
identified in leukemia,4 breast cancer,5 brain cancer,6
prostate cancer, 7 gastrointestinal cancer,8 etc. These 
studies have shown that CSC are responsible for tumor 
growth and metastasis.9
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Although the origins of CSC may vary, they share 
several properties with normal stem cells especially the 
extensive capability of self-renewal.10 CSC can self- 
renew to generate additional CSC and also differentiate 
to generate phenotypically diverse cancer cells with 
limited proliferative potential. The existence of CSC 
might explain why there are so many recurrence, even 
tumor disappeared completely by radiotherapy or 
chemotherapy since CSC have the properties of 
quiescent or slowly proliferating nature,11 the high 
expression level of ATP-binding cassette transporter,12 
the intrinsic high levels of anti-apoptotic molecules, and 
their efficiency of DNA repair.13   
CSC are Regulated by the Niche 
CSC lives in a certain circumstance, named niche. The 
biological behavior of CSC is strictly regulated by the 
signal from niche in the physiological condition.14 On the 
one hand niche sustains both self-renewal and 
characteristics of CSC; on the other hand it also controls 
the quantity and proliferation of CSC, which may be the 
mechanism of cancer prevention in human body.15 As to 
CSC, niche can control the quantity and proliferation of 
CSC by regulating the biological behavior of CSC. It 
was confirmed by the evidence that a tumor had been 
quiescent for 10 years.16 However, if the abnormality 
occurs in the niche, the quantity and proliferation of CSC 
will be out of control, and then cancer relapse and 
metastasis will occur, e.g., abnormal factors, secreted by 
cells nearby niche and extracellular matrix, delivered the 
signal of proliferation may promote cancer progression, 
relapse and metastasis;15 the related signals of self- 
mutation of CSC may lead to the establishment of their 
own niche, 17 and finally the proliferation of niche would 
cause the cancer relapse or metastasis. So CSC is strictly 
regulated by the niche. 
Therapy Discovery for CSC 
The authors have mentioned above that cancer might 
relapse ten years later. Why were cancer cells being 
quiscent for so many years? This can be explained by the 
theories of TCM and CSC. Under normal conditions, 
regulated factors in the niche controlling oncogenes and 
suppressor genes, proliferation, differentiation and 
apoptosis, activation and inactivation of signal trans- 
duction pathways are maintained in a balanced condition 
in order to regulate the normal quantity of stem cells. 
These factors are similar to the yin and yang of TCM 
theory, e.g., for the function of CSC, the authors may 
think that oncogenes are yang, and suppressor genes are 
yin. Once destroyed, the balance of oncogenes (yang) 
and suppressor genes (yin) will not exist, and the 
proliferation of CSC would be out of control. Then 
cancer will occur, and relapse and metastasis will 
develop. If we want to control the proliferation of CSC,
oncogenes (yang) should be suppressed, or suppressor 
genes (yin) should be activated. Therefore, based on the 
principle of yin-yang, the treatment on the regulation of 
the niche of CSC is quite important.  
Since the regulation of CSC is quite complicated, single 
target seems unlikely to change the biological behavior 
of CSC. To date, very few treatments have targeted on 
CSC. However, clinical studies of TCM have confirmed 
its advantages in the treatment and prevention of 
malignant tumor.18,19 Experimental studies also have 
shown that TCM regulates the self-renewal of adult stem 
cells,20-22 e.g., Saponins of Huang Qi (Radix Astragali 
seu Hedysari) specifically promoted neural stem cells to 
differentiate into neurons; 23 Yin Yang Huo (Herba 
Epimedii) flavonoids could promote the proliferation and 
migration of adrenocortical stem cells in rats with 
kidney-yang deficiency;24 as early as 1999 GAO Rui-lan, 
et al. 25 studied that total saponins of panax ginseng had 
an effect on progenitor cells of leukemia which was 
different from the effect on normal progenitor cells, and 
different concentrations of total saponins of panax 
ginseng showed bilateral effects of proliferation and 
suppression. Although the direct objects of these studies 
were not CSC, it provided certain supporting details for 
the hypothesis of TCM on regulating CSC. 
In brief, the mechanisms of the regulation of CSC and 
the balance of yin-yang share many similarities that are 
to regulate the environment from the imbalanced state to 
balanced state. Thus, we propose that the mechanism of 
cancer treatment by TCM may be related to CSC.26
Based on the principle of yin-yang balance, TCM may 
regulate the balance of human internal environment, 
indirectly balance the niche of CSC, and control the 
tumor.  
Summary 
The detection of CSC shed light on the treatment of 
cancer. However, the regulation of CSC is quite 
complicated, single target seems unlikely to change the 
biological behaviors of CSC. TCM has a history of more 
than two thousand years, the principle of which is to 
regulate the disharmonized yin and yang. Just as is 
mentioned in Su Wen (㋴䯂 Plain Questions) “check the 
disharmony of yin-yang, then regulate it until balanced 
conditions”. Therefore, the authors believe that further 
study on the mechanisms of TCM on regulating CSC 
may explore the molecular mechanisms of therapeutic 
effects and provide a potential strategy for eradicating 
cancers. 
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